Lung Clearance Index and Quantitative Computed Tomography of Post-Infectious Bronchiolitis Obliterans in Infants by 源�寃쎌썝 et al.
1ScIentIfIc REPORTS | 7: 15128  | DOI:10.1038/s41598-017-15330-8
www.nature.com/scientificreports
Lung Clearance Index and 
Quantitative Computed 
Tomography of Post-Infectious 
Bronchiolitis Obliterans in Infants
Yoon Hee Kim1,4, Hyun Joo Shin2,4, In Suk Sol3,4, Soo Yeon Kim3,4, Jong Deok Kim3,4, Haesung 
Yoon2,4, Kyung Won Kim3,4, Myung-Joon Kim2,4, Mi-Jung Lee2,4 & Myung Hyun Sohn  3,4
Post-infectious bronchiolitis obliterans (BO) could be diagnosed via spirometry and chest computed 
tomography (CT); however, these tests are limited in infants. We aimed to evaluate the utility of lung 
clearance index (LCI) and air-trapping lung volume from chest CT in infants. This prospective study 
included 20 infants (mean age, 10.9 ± 6.3 months) diagnosed with post-infectious BO between 2009 
and 2016. All subjects underwent multiple breath washout tests. For quantitative analysis of chest CT, 
the mean lung area attenuation value was used as an individual cutoff to determine the air-trapping 
lung volume. The mean cutoff lung attenuation value was −659 Hounsfield units, the mean total 
lung volume was 265 ml, and the mean air-trapping lung volume percentage was 22.9%. Functional 
residual capacity correlated with total lung volume and normal attenuation lung volume (p < 0.02). LCI 
(p < 0.02) and moment ratio (MR) 1 (p < 0.05) correlated with the air-trapping lung volume percentage. 
The concordance indices of LCI (0.659, p = 0.025) and MR1 (0.642, p = 0.046) were significantly 
correlated with the air-trapping lung volume percentage from CT. LCI and quantitative air-trapping lung 
volume from chest CT are feasible, complimentary tools for assessing infants with post-infectious BO.
Post-infectious bronchiolitis obliterans (BO) is the partial or complete obstruction of small airways by inflamma-
tion, granulation tissue, and/or fibrosis from recurrent pulmonary infection, especially during very early child-
hood (<6 months old)1. Recurrent epithelial injury in the bronchioles causes progressive narrowing, scarring, 
and chronic obstruction of the small airways2, resulting in multifocal air-trapping, bronchial wall thickening, 
bronchiectasis, and atelectasis, causing chronic severe symptoms in children3. A recent cohort study reported 
severely impaired pulmonary function among children with post-infectious BO after long-term follow-up4. 
Disproportional growth of lung parenchyma in airways of affected children was a proposed explanation for severe 
complication of post-infectious BO5. Therefore, early and accurate diagnosis of post-infectious BO in infants is 
critical to provide effective interventions and to predict disease outcome.
Diagnosis of post-infectious BO is usually based on clinical and radiological findings4. The spirometry aids 
the diagnosis of post-infectious BO in children, and it detects irreversible bronchiolar obstruction, and impaired 
lung distensibility6. However, the use of spirometry in infant with post-infectious BO is not feasible due to lim-
ited cooperation. Previous studies of spirometry in post-infectious BO usually focused on follow-up results4,7,8. 
Multiple breath washout (MBW) to calculate lung clearance index (LCI) has emerged as a sensitive marker to 
detect early small airway abnormalities; it has good reproducibility and accuracy in pediatric populations, includ-
ing infants9. However, few studies have investigated LCI in post-infectious BO in infants, whereas several studies 
evaluated LCI in cystic fibrosis, asthma, and chronic lung disease in premature infants10–13.
Post-infectious BO can be diagnosed with high-resolution chest computed tomography (CT). The widely 
accepted radiological findings are bronchial wall thickening, bronchiectasis, segmental/subsegmental atelectasis, 
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and mosaic attenuation patterns due to constrictive small airway obliteration14–16. CT is widely available in most 
institutes, and one study has demonstrated diagnostic value for gross CT findings in post-infectious BO6. Two 
studies attempted to quantify CT findings in children with BO17,18. However, to our knowledge, no previous study 
has quantitatively analyzed air-trapping lung area in chest CT in infants with post-infectious BO.
This study had two objectives: (1) to determine the usefulness of LCI from MBW and quantification of 
air-trapping lung volume from chest CT for assessing the degree of small airway obstruction in infants with 
post-infectious BO, and (2) to identify existing correlations between LCI and air-trapping lung volume measured 
in chest CT scans of infants.
Results
Subject Characteristics, Quantitative CT Assessment, and Infant PFT. The clinical characteristics 
of all 20 infants diagnosed with post-infectious BO in this study are presented in Tables 1 and 2. The mean age 
at the time of diagnosis was 10.9 months, and 18 infants (90%) were male. The mean percentiles of height and 
weight were 56.6 and 52.2, respectively. The pathogens involved in the initial lower respiratory infection that 
might cause post-infectious BO included adenovirus, parainfluenza, and Mycoplasma pneumoniae. The mean 
duration of recurrent and persistent airway obstruction symptoms were 3 months, and the mean interval period 
between infant PFT and chest CT was 13.5 days.
The results of quantitative CT assessment are presented in Fig. 1 and Table 1. The mean attenuation of normal 
lung area (HUn) was −560 HU, and that of air-trapping lung area (HUa) was −759 HU. The mean cutoff lung 
attenuation (HUc) was −659 HU. The mean calculated total lung volume was 265 ml, and the mean percentage of 
air-trapping lung volume was 22.9%.
The results of infant PFT with bronchodilator treatment are presented in Table 2. The mean LCI values before 
and after bronchodilator were 8.38 and 8.88, respectively. The tidal breathing ratio (tPTEF/tE) and FRC differed 
before and after bronchodilator treatment, whereas LCI, MR1, and MR2 did not differ.
Quantitative CT Assessment and Infant PFT Parameters. LCI, MR1, MR2, and tidal breathing 
ratio were possible indices of small airway obstruction. Therefore, general correlations between these infant PFT 
parameters and the air-trapping lung volume percentage of the quantitative CT were analyzed in a correlation 
matrix (Fig. 2). The tidal breathing ratio (tPTEF/tE) did not tend to correlate with air-trapping lung volume per-
centage, whereas the other parameters before bronchodilator treatment tended to correlate with air-trapping lung 
volume percentage. All MBW parameters, LCI, MR1, and MR2, were well-correlated with each other.
FRC values before and after bronchodilator were well-correlated with total lung volume and normal atten-
uation lung volume of the quantitative CT assessment (Table 3 and Fig. 3). The correlation matrix analysis 
revealed that LCI, MR1, and MR2 seemed to be related to the air-trapping lung volume percentage. Thus, partial 
Subjects (n = 20)
Age at diagnosis, month 10.9 ± 6.3
Male gender, no (%) 18 (90)
Causative pathogen of initial lower respiratory infection, no (%)
  Adenovirus 2 (10)
  Influenza 1 (5)
  Parainfluenza 4 (20)
  Respiratory syncytial virus 2 (10)
  Metapneumovirus 2 (10)
  Mycoplasma pneumoniae 3 (15)
  Other 3 (15)
  Unknown 3 (15)
Duration of recurrent airway obstruction symptoms, month 3.0 (2.0−3.8)
Interval between infant PFT and CT, day 13.5 (2.8−54.0)
Quantitative CT
Measured attenuation
  Normal lung area attenuation (HUn), HU −560 ± 68
  Air-trapping lung area attenuation (HUa), HU −759 ± 60
  Cutoff lung attenuation (HUc), HU −659 ± 60
Calculated lung volume
  Total lung volume, ml 265 ± 127
  Normal attenuation lung volume, ml 191 ± 72
  Air-trapping lung volume, ml 43 (11−120)
  Air-trapping lung volume percentage, % 22.9 ± 18
Table 1. Subject Characteristics and Quantitative Computed Tomography Assessment. Data are expressed 
as number (percentage), mean ± standard deviation, or median (interquartile range). PFT, infant pulmonary 
function test; CT, computed tomography; HU, Hounsfield units.
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correlation analysis was conducted on these data using additional models that adjusted for confounding factors. 
Infant age, gender, height, and weight were adjusted in model 2. In model 3, these four factors, as well as the inter-
val between PFT and CT scan, were adjusted. LCI and MR1 before bronchodilator treatment were well-correlated 
with air-trapping lung volume percentage in all models. LCI and MR1 after bronchodilator were correlated with 
air-trapping lung volume percentage only in model 1, and these correlations were not preserved after adjusting 
for the confounding factors considered in models 2 and 3. MR2 was not significantly correlated with air-trapping 
lung volume percentage in any model.
Concordance between Quantitative CT Assessment and Infant PFT Parameters. The concord-
ance index between air-trapping lung volume percentage and MBW parameters are presented in Table 4. The 
concordance index of LCI and MR1 before bronchodilator was significant (0.659 with p = 0.025 for LCI; 0.642 
with p = 0.046 for MR1). No other values had significant concordance indices with respect to air-trapping lung 
volume percentage.
Discussion
Our study demonstrates the usefulness of MBW for calculating FRC and LCI and chest CT for quantifying 
the air-trapping lung volume; these parameters enable assessment of small airway obstruction in infants with 
post-infectious BO. Normal and air-trapping lung areas on CT images were differentiated using the mean lung 
area attenuation value as a cutoff attenuation value (HUc). The calculated air-trapping lung area showed good 
correlation and concordance with LCI, implicating airway obstruction in infants with post-infectious BO.
Post-infectious BO frequently affects infants younger than 6 months of age. It causes severe, irreversible, and 
persistent small airway obstruction and impairs pulmonary function as the child develops19. Several studies have 
used serial spirometry to demonstrate functional impairment in children afflicted with post-infectious BO2,4,5. 
However, data are lacking regarding the initial diagnosis of post-infectious BO using PFT in infants. Few stud-
ies have investigated computational quantification of air-trapping lung volume in infant chest CT images for 
post-infectious BO either.
Spirometry and chest CT are considered to be the most useful objective assessment tools for chronic lung 
disease in infants and children. However, these tools are not sensitive enough to detect early airway changes20. 
Several recent studies of cystic fibrosis in children suggested the usefulness of LCI for assessing early stages of 
chronic lung disease, and demonstrated good correlation with structural lung abnormalities in chest CT10,11,21,22. 
This study showed that LCI also was a good index for evaluating lung abnormalities in infants with post-infectious 
BO, another chronic lung disease that results in severe insult to the lower respiratory tract19.
CT is usually more valuable than spirometry to diagnose post-infectious BO because CT findings, such as 
mosaic attenuation, can be more specific than spirometry findings, such as fixed airway obstruction22,23. To assess 
treatment response or follow-up, spirometry is usually preferred over CT because it reflects clinical symptoms 
and performance. Moreover, CT images are difficult to quantitate and repeated CT scans are potentially harmful 
due to cumulative radiation exposure22–24. However, because spirometry in infants or young children is difficult 
due to limited cooperation, there is no choice but to use CT to assess follow-up3,25. Our study is meaningful 
because it not only suggests that CT quantification is feasible and reliable, but also that the MBW test is useful to 
assess infant pulmonary function in post-infectious BO.
All subjects in this study had good prognoses within the spectrum of post-infectious BO because they were 
discharged from the hospital without any oxygen or mechanical ventilation therapy or morbidity. This study 
showed that LCI and quantification of air-trapping lung areas from chest CT was feasible for post-infectious BO 
Subjects (n = 19)
Age at infant PFT, month
Height, cm 76.8 ± 9.4
Height percentile for same age and gender 56.6 ± 33.5
Weight, kg 9.7 ± 2.4
Weight percentile for same age and gender 52.2 ± 33.3
Infant PFT Before BD treatment After BD treatment p
Tidal breathing
Tidal volume, ml 77.8 ± 35.1 83.8 ± 36.1 0.172
Respiratory rate breaths per min 34.5 ± 6.3 34.2 ± 6.1 0.625
Tidal breathing ratio (tPTEF/tE) 29.3 ± 13.2 24.5 ± 7.1 0.042
Multiple breath washout
Functional residual capacity (FRC), ml 167 ± 52 151 ± 39 0.014
Lung clearance index (LCI) 8.38 ± 1.81 8.88 ± 1.71 0.225
Moment ratio 1 (M1/M0) 2.65 ± 0.68 2.80 ± 0.61 0.241
Moment ratio 2 (M2/M0) 13.83 ± 8.25 15.15 ± 7.52 0.365
Table 2. Infant Pulmonary Function Tests with Bronchodilator. Data are expressed as number (percentage), 
mean ± standard deviation, or median (interquartile range). BD, bronchodilator; PFT, pulmonary function test; 
p, paired t-test.
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in infants; therefore, the usefulness of these two tools could be tested for assessing the early stage lung abnormali-
ties. The LCI values before and after bronchodilator treatment were 8.38 and 8.88, respectively, which were above 
the cutoff values of approximately 7.0 to 7.5 suggested in other studies, indicating that LCI could be used as an 
independent marker for evaluating lung abnormality in post-infectious BO11,21,26. Future studies that include a 
healthy control population and many subjects with post-infectious BO are needed to determine a reliable cutoff 
value of LCI.
Although the MR could be more sensitive than LCI for detecting the early lung abnormalities, it is not yet 
acceptable in clinical relevance and various researches11,27. Here, MR1 showed good correlation with air-trapping 
lung volume from the chest CT scan, possibly because MR2, which reflected the latter portion of the washout 
curve, could be unstable in a small unhealthy infant who could have some difficulty performing the MBW test, 
especially during sedation. For this reason, different cutoffs of LCI and MR were suggested for better diagnostic 
performance according to the different final gas concentration26,28. Here, the tidal breathing ratio (tPTEF/tE) was 
not correlated with the air-trapping lung volume from chest CT or with the MBW parameters (LCI and MR). 
These results were consistent with those from studies on infant cystic fibrosis29.
There has been some controversy regarding bronchodilator response in post-infectious BO, although fixed 
irreversible airway obstruction is widely accepted1. A subsequent treatment involving an inhaled corticosteroid 
and a bronchodilator is recommended in cases where the patient experiences improvement in airway obstruction 
after a bronchodilator treatment1. All subjects in our study inhaled a short-acting bronchodilator during hospital-
ization. We could not control for inhaled bronchodilator use before chest CT; therefore, we analyzed infant PFT 
parameters before and after bronchodilator. The good correlation of LCI and MR1 with air-trapping lung volume 
from CT was preserved independent of bronchodilator use.
Several studies have attempted to define and quantify chest CT findings for the assessment of small airway 
disease. Direct quantification of small airways (<2 mm in diameter) is not possible using CT scans because the 
resolution of the scan does not permit it. Therefore, quantification of air-trapping area on expiratory phase CT 
has been evaluated to assess small airway disease30. Previous studies in adults used threshold values of -856 or 
-950 HU for quantification of air-trapping areas in chronic obstructive pulmonary disease or emphysema, and 
recent studies used attenuation differences between inspiration and expiration CT images to determine accurate 
threshold attenuation values30–32.
The method used to define the cutoff value between normal and air-trapping lung areas in CT has not yet been 
standardized in children. The normal lung attenuation value is higher in children than in adults, and increases 
in younger children33. A previous study reported that the lung attenuation value in neonates was -380 HU33. 
Therefore, the adult threshold value is not suitable for children and infants. The first attempt to quantify the 
air-trapping lung area in pediatric chest CT was reported by Kim et al.18. They calculated individualized threshold 
values using mean lung area attenuation values in children with BO from graft-versus-host disease (GVHD), 
rather than using fixed threshold values. Here, we used this same method, and demonstrated the feasibility of this 
method in infants with post-infectious BO. The quantified lung volumes in CT were significantly correlated with 
FRC and LCI.
We also demonstrated the usefulness of advanced computational tools that can perform segmentation accord-
ing to lung parenchymal attenuation. It is challenging to differentiate air-trapping areas according to the HU 
values in routine chest CT in infants, because deep inspiration images cannot be obtained, respiratory rates are 
normally faster in infants, and the image contrast from soft tissue is limited in the small thoracic cage of infants. 
Most studies use qualitative or semi-quantitative methods, such as scoring systems for pediatric chest CT11,34,35. 
A few quantitative methods have been applied for children > 2 years old with cystic fibrosis or GVHD-related 
BO18,36,37. One study calculated airway and lung volumes for infants with chronic lung disease, and another study 
Figure 1. Quantitative chest CT assessment in a 21-month-old boy with post-infectious bronchiolitis 
obliterans. (A) Coronal image shows differing multifocal attenuation areas in both lungs from air-trapping 
and normal aeration. Normal lung attenuation value (HUn) was -568.4 HU and air-trapping lung attenuation 
(HUa) was -836.8 HU in this patient. (B) Both lungs were segmented computationally by applying the cutoff 
attenuation value (HUc, -702.6 HU for this patient). The same coronal image in part (A) shows the air-trapping 
areas in green, the normally aerated lung in orange, and the excluded airway in blue. (C) The 3D color image 
shows the calculated total lung volume (454 ml), air-trapping lung volume (151 ml), and air-trapping lung 
volume percentage (33.2%) in this patient.
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used xenon-ventilated dual-energy CT to differentiate air-trapping areas in pediatric lungs17,38. Our study was the 
first attempt to demonstrate the utility of routine chest CT for quantitative assessment of air-trapping lung volume 
and lung function in infants. Chest CT with variable breath phases could be used to quantify lung volumes with 
different attenuations, and this comparative method, like PFT, can be used to evaluate obstructive airway disease.
The study has several limitations and strengths. First, the study size was small because few infants diagnosed 
with post-infectious BO underwent both infant PFT and chest CT. Despite its size, this study is meaningful 
because it represents the first attempt to use both initial PFT and quantitative air-trapping lung volume analysis of 
chest CT in infants with post-infectious BO, and the results indicate clinical utility. To overcome statistical limi-
tations from study size, we conducted concordance analysis additionally using matching orders of two variables. 
Second, the measured amount of air-trapping lung volume can be affected by different breathing phases, different 
CT machines, and different CT parameters. We could not control specific breathing maneuvers in infants under 
shallow sedation without intubation or ventilation. The correlation coefficient or p value would likely be more 
significant if the air-trapping lung volume in full expiration phase could be obtained. This was a long-term study 
(8 years), and thus the CT machines and parameters in use changed with time. However, the results found here 
provide rationale for future studies using the same CT protocol and respiratory phase.
This study clarified that the initial LCI and method to quantify air-trapping lung volume from chest CT 
are feasible and useful for assessing obstructive small airway disease in infants with post-infectious BO. The 
use of mean lung area attenuation value as a cutoff attenuation value was appropriate to quantify normal and 
air-trapping lung areas in infant chest CT. Initial LCI and air-trapping lung volume percentage in chest CT 
Figure 2. Scatter plot matrix illustrates the general correlation among air-trapping area percentage of chest CT 
and infant pulmonary function test parameters representing small airway obstruction, lung clearance index 
(LCI), moment ratio (MR)1, MR2, and tidal breathing ratio (tPTEF/tE) before and after bronchodilator (BD) 
treatment. The variables are written in a diagonal line from top left to bottom right. Each variable is plotted 
against all others in the left lower triangle, and the correlation significance is shown as a circle (blue circle, 
positive correlation; red circle, negative correlation).
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showed good correlation and concordance. These could provide supplementary tools for diagnosis and follow-up 
of lung function in infants with post-infectious BO.
Methods
Study Design and Subjects. Infants diagnosed with post-infectious BO between 2009 and 2016 at the 
Severance Children’s Hospital were enrolled. All subjects were < 2 years old at the time of initial diagnosis. The 
post-infectious BO diagnosis was based on the following: (1) history of lower respiratory infection before at least 
60 days; (2) persistent or recurrent airway obstruction symptoms characterized by tachypnea, increased anter-
oposterior chest diameter, crackles, wheezing, and hypoxemia for at least 60 days; (3) typical chest CT images 
such as mosaic attenuation, air-trapping, bronchial wall thickening, bronchiectasis, and/or segmental/subseg-
mental atelectasis14–16. Patients were excluded if they had other chronic lung diseases (e.g., asthma, bronchopul-
monary dysplasia, aspiration pneumonia) or other conditions that could affect lung function (e.g., congenital 
heart disease, neuromuscular disease, severe developmental delay, prematurity less than 34 weeks’ gestation).
After initial diagnosis, all infants underwent infant pulmonary function test (PFT) at the next visit to the 
out-patient clinic, and were asked to interrupt their inhaled or oral corticosteroid and/or β2-agonist for at least 
24 h before the infant PFT. None of the subjects had symptoms of acute respiratory infection, such as fever or 
acute exacerbation, for at least 1 week before the infant PFT.
This study was approved by the Institutional Review Board of Severance Hospital (Protocol no. 4-2007-0255) 
and all methods in this study were performed in accordance with the relevant guidelines and regulations of this 
ethics commitee. Written informed consent was obtained from the parents.
Quantification of Air-Trapping in Chest CT. All infants underwent CT scans of the chest and details 
regarding the methods of CT scan are provided in an online data supplement.
One of two experienced pediatric radiologists quantified normal and air-trapping lung areas (Fig. 1). The 
radiologist reviewed chest CT images in soft kernel with a lung window setting of 1500/−500 Hounsfield units 
(HU) using a picture archiving and communication system (PACS) workstation (Centricity Radiology RA1000; 
GE Medical Systems, Milwaukee, WI). Using the most representative axial image that clearly depicted both nor-
mal and air-trapping lung areas without artifact, two circular regions of interest (ROIs) with 2−3 mm diameter 
were drawn in each area, avoiding pulmonary vessel, airways, or dependent portions of both lungs to minimize 
the effect of dependent atelectasis in infants. The average attenuation values of normal (HUn) and air-trapping 
(HUa) lung areas within the ROIs were automatically computed based on the delineated ROIs. Then, the cut-
off attenuation (HUc) was calculated as the mean lung area attenuation value using the following equation: 
HUc = (HUn + HUa)/2. The HUn, HUa, and HUc values were recorded for each patient.
Lung parenchyma was segmented computationally by subtracting chest wall, mediastinum, and grossly visi-
ble major airways from CT images using Aquarius iNtuition Viewer (version 4.4.12, TeraRecon, San Mateo, CA, 
USA). Next, the air-trapping and normal lung areas were segmented in both lungs according to the calculated 
HUc value. The normal lung attenuation was defined as the area with a higher attenuation value than the HUc, 
whereas air-trapping lung was defined as the area with a lower attenuation value than the HUc. The volume 
of each area was automatically computed. We also did visual checks to make sure that the trapped air detec-
tion reasonably approximated the visual appearance. Total lung volume, normal attenuation lung volume, and 
air-trapping lung volume were recorded. The percentage of air-trapping lung volume was calculated by dividing 
the air-trapping lung volume by the total lung volume.
Quantitative CT parameters
FRC before BD treatment FRC after BD treatment
r (p) r (p)
Total lung volume, ml 0.518 (0.019) 0.533 (0.015)
Normal attenuation lung volume, ml 0.656 (0.002) 0.678 (0.001)
LCI before BD treatment LCI after BD treatment
r (p) r (p)
Air-trapping lung volume percentage, %
Model 1 0.541 (0.014) 0.550 (0.012)
Model 2 0.627 (0.009) 0.498 (0.049)
Model 3 0.608 (0.016) 0.465 (0.081)
Before BD treatment, r (p) After BD treatment, r (p)
MR1 MR2 MR1 MR2
Model 1 0.456 (0.044) 0.377 (0.101) 0.483 (0.031) 0.404 (0.077)
Model 2 0.519 (0.039) 0.400 (0.125) 0.477 (0.061) 0.439 (0.089)
Model 3 0.518 (0.048) 0.429 (0.111) 0.448 (0.094) 0.406 (0.133)
Table 3. Correlation Analysis Between MBW Parameters and Quantitative Computed Tomography Assessment 
Parameters. Data are expressed as r (correlation coefficient) and p value adjusting for age, gender, height, 
and weight in model 2, and adjusting additionally for interval between infant PFT and CT in model 3. BD, 
bronchodilator; MBW, multiple breath washout; CT, computed tomography; FRC, functional residual capacity; 
LCI, lung clearance index; MR, moment ratio; PFT, pulmonary function test.
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Infant Pulmonary Function Tests. Multiple breath washout (MBW) tests were conducted using the 
EXHALYZER D system (Eco Medics AG, Durnten, Switzerland) with 4% sulfur hexafluoride (SF6). Subjects 
were sedated with orally administered chloral hydrate (60−100 mg/kg). The PFT was conducted in the supine 
position, with the infant’s head in the midline using a size 0 round infant silicone face mask placed over the nose 
and mouth. Details regarding the methodology used for performing of infant PFT are provided in an online data 
supplement.
Reversibility testing with a bronchodilator was conducted for tidal breathing flow-volume loops (TBFVL) and 
MBW tests. Salbutamol (2.5 mg/2.5 ml) was administered with a Pari LC-Jet Plus nebulizer and a face mask (Pari 
Respiratory Equipment, Starnberg, Germany). TBFVL and MBW tests were conducted before the administration 
of nebulized salbutamol and 15 min after administration.
The following infant PFT data were derived from the tidal breathing test: tidal volume, respiratory rate breaths 
per min, and tidal breathing ratio (time to peak expiratory flow/expiratory time, tPTEF/tE). Functional residual 
capacity (FRC), LCI, moment ratio 1 (MR1; M1/M0), and moment ratio 2 (MR2; M2/M0) were derived from the 
MBW test.
Statistical Analysis. Reported values in the text and tables are means ± standard deviation, median values 
with interquartile ranges, or number and percentage, as appropriate. Differences in PFT parameters obtained 
before and after bronchodilator were analyzed by the paired t-test. Correlation matrix, Pearson’s correlation, and 
partial correlation analyses were used to assess the relationship between PFT parameters and quantitative CT 
assessment parameters. FRC was compared with total lung volume and normal attenuation lung volume on CT 
using Pearson’s correlation analysis. LCI was compared with air-trapping lung volume percentage using Pearson’s 
Figure 3. Scatter plots for correlation analyses of the quantitative chest CT assessment and multiple breath 
washout (MBW) parameters. Normal attenuation lung volume and functional residual volume (FRC) (A) 
before bronchodilator (BD) treatment, and (B) after BD treatment. Air-trapping lung volume percentage and 
lung clearance index (LCI) (C) before BD treatment, and (D) after BD treatment.
Air-trapping lung volume percentage, % Concordance index (SE) 95% CI p
LCI
Before BD treatment 0.659 (0.071) 0.518, 0.795 0.025
After BD treatment 0.648 (0.076) 0.500, 0.789 0.051
MR1
Before BD treatment 0.642 (0.071) 0.503, 0.776 0.046
After BD treatment 0.624 (0.074) 0.479, 0.758 0.094
MR2
Before BD treatment 0.620 (0.073) 0.474, 0.753 0.100
After BD treatment 0.607 (0.074) 0.468, 0.747 0.148
Table 4. Concordance Analysis Between Lung Clearance Index and Air-Trapping Lung Volume Percentage. 
Data are expressed as concordance index (SE). BD, bronchodilator; LCI, lung clearance index; MR, moment 
ratio; SE, standard error; CI, confidence interval. *P was determined using bootstrapping methods.
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and partial correlation analyses, adjusting for age, gender, height, and weight in model 2 and additionally adjust-
ing for interval between PFT and CT in model 3. The inhaled short-acting bronchodilator treatment could not be 
controlled before CT scanning; therefore, PFT parameters before and after inhalation of the short-acting bron-
chodilator were compared using the air-trapping lung volume percentage.
Concordance analysis was used to assess the relationship between PFT parameters and quantitative CT assess-
ment parameters. The concordance index between two parameters, standard error, and 95% confidence interval 
were calculated using the bootstrapping method39. A correlation matrix was generated with Pearson’s correlation 
analysis for overall assessment of the relationship of air-trapping lung volume percentage on chest CT with airway 
obstruction parameters such as tidal breathing ratio (tPTEF/tE) on PFT and ventilation inhomogeneity such as LCI, 
MR1, and MR2.
The correlation matrix, the partial correlation scatter plot of model 2, and the concordance analysis were 
conducted in the R statistical package (R version 3.2.5.; Institute for Statistics and Mathematics, Vienna, Austria; 
www.R-project.org). All other analyses were performed using SPSS version 23 (IBM Corp., Armonk, NY, USA). 
Any p value < 0.05 was considered statistically significant.
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